BrainStorm Cell Therapeutics Aligns with FDA on Phase 3b NurOwn Clinical Trial CMC Aspects
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, has reached an important milestone by aligning with the U.S. Food and Drug Administration (FDA) on the Chemistry, Manufacturing, and Controls (CMC) aspects of its Phase 3b clinical trial for NurOwn®, an investigational therapy for amyotrophic lateral sclerosis (ALS). This […]
Controversial Utah Bill Threatens FDA’s Authority Over Stem Cell Therapies
In a concerning development for the field of stem cell research and therapy, the International Society for Cell & Gene Therapy (ISCT) has voiced its opposition to a proposed bill in Utah that could undermine the U.S. Food and Drug Administration’s (FDA) ability to regulate stem cell products and protect patient safety. The bill, known as the “Right to […]
Unleashing the Power of Stem Cells: STEMREGEN® Launches Three Innovative Supplements at Biohacking Conference
In a groundbreaking announcement at the Biohacking Conference in Dallas, Texas, STEMREGEN® unveiled three new stem cell-boosting supplements designed to enhance the body’s natural repair system. As the pioneer in stem cell science-backed supplements, STEMREGEN® continues to lead the way with innovative products that support healthy aging and athletic recovery. STEMREGEN® Release: Enhancing Innate Repair […]
REPROCELL USA Launches Advanced GMP Facility for Stem Cell Manufacturing
REPROCELL USA has marked a significant milestone with the inauguration of its state-of-the-art GMP manufacturing facility dedicated to producing high-quality stem cells. This facility, located in Beltsville, Maryland, was officially opened on May 15, 2024, by Mr. Kevin Anderson, Secretary of the Department of Commerce, State of Maryland. The new facility is designed to manufacture […]
New York Blood Center Expands GMP Cell & Gene Therapy Manufacturing in Louisville
New York Blood Center Enterprises (NYBCe) has announced the grand opening of its new GMP facility in Louisville, Kentucky. This state-of-the-art site, part of Comprehensive Cell Solutions (CCS), enhances cell and gene therapy manufacturing capabilities, offering end-to-end services from cell sourcing to cryopreservation and GMP manufacturing. The Louisville facility includes apheresis suites, cleanrooms, and quality […]
Immorta Bio Inc. Announces Breakthrough in Liver Failure Treatment with Stem Cell Technology
Immorta Bio Inc., a company focused on longevity and regenerative medicine, has announced a significant breakthrough in the treatment of liver failure. The company is developing personalized stem cell technologies that show great promise in combating various diseases of aging. Immorta Bio’s research pipeline includes Personalized Regenerative Cells (PRCs), Personalized Mesenchymal Stem Cells (pMSCs), and […]
Theradaptive Secures Landmark Funding to Propel Human Clinical Trials in Stem Cell Research
In a groundbreaking development for stem cell research and regenerative medicine, Theradaptive has secured significant funding from the Maryland Stem Cell Research Fund (MSCRF). This crucial financial boost will support the advancement of their innovative human clinical trials, marking a significant milestone in the field of biotechnology. Theradaptive, a pioneering biopharmaceutical company, is renowned for […]
Revolutionary Stem Cell Technology Trials Could Cure Paralysis
Queensland researchers believe a cure for paralysis is within reach. The team’s ground-breaking therapy involves taking cells from the patient’s nose and transplanting them into the spinal cord of the same patient. This revolutionary stem cell technology is ready for human trials. Visit Perry Cross Spinal Research Foundation for more info.
Will CPI Stem Cells Achieve FDA Approval? Scotty Nelson Discusses the Future of Regenerative Medicine
In a recent discussion, Scotty Nelson, co-founder of the Cellular Performance Institute (CPI) Stem Cells, delved into the complexities and potential of stem cell therapy, particularly focusing on the possibility of FDA approval for CPI’s innovative treatments. CPI Stem Cells, located in Tijuana, Mexico, is at the forefront of regenerative medicine, offering advanced stem cell […]
Aspen Neuroscience Secures CIRM Grant for Groundbreaking Parkinson’s Disease Stem Cell Therapy
In a significant stride towards combating Parkinson’s disease, Aspen Neuroscience has been awarded a prestigious CLIN2 grant by the California Institute for Regenerative Medicine (CIRM). This milestone funding will accelerate the development of their innovative stem cell therapy, ANPD001. Aspen Neuroscience’s proprietary approach leverages cutting-edge induced pluripotent stem cells (iPSCs) to create personalized therapies aimed […]